SAN DIEGO—Gastroesophageal reflux disease is the most common indication for esophagogastroduodenoscopy despite the fact that about 40% of patients with esophageal adenocarcinoma don’t report prior GERD. New data suggest screening strategies for Barrett’s esophagus and EAC need to go well beyond a GERD-centric approach.
“Our aim was to compare risk factors between EAC patients who reported prior GERD symptoms with EAC patients who did not report any prior GERD